Literature DB >> 22502683

Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis.

Zhongliang Wang1, Yao Chen, Xiaofeng Li, Li Xu, Wei Ma, Lingmei Chang, Funian Ju.   

Abstract

OBJECTIVES: Expression of vascular endothelial growth factor C (VEGF-C)and vascular endothelial growth factor receptor-3 (VEGFR-3) in laryngeal squamous carcinoma and its relationship to lymph node metastasis were investigated.
METHODS: VEGF-C and VEGFR-3 gene expression in 30 cases of normal laryngeal mucosa tissue (NLM), primary laryngeal carcinoma cell carcinomas (PLC) and cervical lymph nodes (CLN) was examined by reverse transcription polymerase chain reaction (RT-PCR). Protein levels of VEGF-C expression were determined by immunohistochemical staining in 60 cases of PLC.
RESULTS: Expression of VEGF-C and VEGFR-3 different among NLM, PLC and CLN in the same patient. In PLC, expression was significantly higher in lymph node positive group than in the lymph node negative group and associated with histological grade of differentiation; Expression of VEGF-C and VEGFR-3 was not linked with age, sex, site or T stage.
CONCLUSIONS: A close correlation was found between VEGF-C/VEGFR-3 expression and lymph node metastasis in PLC, suggesting a role in metastasis of laryngeal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22502683     DOI: 10.7314/apjcp.2012.13.1.027

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.

Authors:  N D Seibold; S E Schild; K L Bruchhage; M P Gebhard; F Noack; D Rades
Journal:  Strahlenther Onkol       Date:  2013-06-09       Impact factor: 3.621

Review 2.  Opposing Roles of Vascular Endothelial Growth Factor C in Metastatic Dissemination and Resistance to Radio/Chemotherapy: Discussion of Mechanisms and Therapeutic Strategies.

Authors:  Christopher Montemagno; Frédéric Luciano; Gilles Pagès
Journal:  Methods Mol Biol       Date:  2022

3.  CXCR4 silencing inhibits invasion and migration of human laryngeal cancer Hep-2 cells.

Authors:  Juntao Niu; Yongwang Huang; Lun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.

Authors:  Anke Schlüter; Patrick Weller; Oliver Kanaan; Ivonne Nel; Lukas Heusgen; Benedikt Höing; Pia Haßkamp; Sebastian Zander; Magis Mandapathil; Nina Dominas; Judith Arnolds; Boris A Stuck; Stephan Lang; Agnes Bankfalvi; Sven Brandau
Journal:  BMC Cancer       Date:  2018-03-09       Impact factor: 4.430

Review 5.  Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.

Authors:  Ming-Chuan Hsu; Mei-Ren Pan; Wen-Chun Hung
Journal:  Cells       Date:  2019-03-21       Impact factor: 6.600

6.  Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.

Authors:  Nabil F Saba; Pooja Vijayvargiya; Jan B Vermorken; Juan P Rodrigo; Stefan M Willems; Nina Zidar; Remco de Bree; Antti Mäkitie; Greg T Wolf; Athanassios Argiris; Yong Teng; Alfio Ferlito
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

7.  Correlation between vascular endothelial growth factor expression and presence of lymph node metastasis in advanced squamous cell carcinoma of the larynx.

Authors:  Rodrigo Gonzalez Bonhin; Vanessa Brito Campoy Rocha; Guilherme Machado de Carvalho; Alexandre Caixeta Guimarães; Agrício Nubiato Crespo; Carlos Takahiro Chone; Eliane M I Amstalden
Journal:  Braz J Otorhinolaryngol       Date:  2014-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.